Skip to content

NuSkin Enterprises NUS Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
Lifevantage Corporation logo
Lifevantage CorporationLFVN
USANA Health Sciences logo
USANA Health SciencesUSNA
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
The Beauty Health Company logo
The Beauty Health CompanySKIN
Kenvue logo
KenvueKVUE

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's common stock, shares authorized (in shares)?
NuSkin Enterprises (NUS) reported common stock, shares authorized (in shares) of $500M in Q1 2026.
How has NuSkin Enterprises's common stock, shares authorized (in shares) changed year-over-year?
NuSkin Enterprises's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $500M to $500M.
What is the long-term trend for NuSkin Enterprises's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), NuSkin Enterprises's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $500M to $500M.